机构:[1]Department of Nephrology, Xuanwu Hospital of Capital Medical University, Changchun Street 45#, Beijing 100053, China肾科首都医科大学宣武医院[2]Central Hospital of Cangzhou, Xinhua Middle Street 201#, Cangzhou, Hebei Province 061001, China[3]Department of Life Sciences, The National Natural Science Foundation of China, Shuangqing Road 83#, Beijing 100085, China
Objectives. We aim to identify the key biomarker of acute rejection (AR) after kidney transplantation via bioinformatics methods. Methods. The gene expression data GSE75693 of 30 samples with stable kidney transplantation recipients and 15 AR samples were downloaded and analyzed by the limma package to identify differentially expressed genes (DEGs). Then, Gene Ontology (GO) functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were done to explore the biological functions and potential important pathways of DEGs. Finally, protein-protein interactions (PPIs) and literature mining were applied to construct the cocitation network and to select the hub protein. Results. A total of 437 upregulated genes and 353 downregulated genes were selected according to P < 0 01 and log(2) fold change > 1 0. DEGs of AR are mainly located on membranes and impact the activation of receptors in immune responses. In the PPI network, Src kinase, lymphocyte kinase (LCK), CD3G, B2M, interferon-gamma, CD3D, tumor necrosis factor, VAV1, and CD3E in the T cell receptor signaling pathway were selected as important factors, and LCK was identified as the hub protein. Conclusion. LCK, via acting on T-cell receptor, might be a potential therapeutic target for AR after kidney transplantation.
基金:
The study was supported by grants from Wu Jieping Medical Foundation Clinical Research Funding (no. 320.6750.16050).
第一作者机构:[1]Department of Nephrology, Xuanwu Hospital of Capital Medical University, Changchun Street 45#, Beijing 100053, China
通讯作者:
通讯机构:[1]Department of Nephrology, Xuanwu Hospital of Capital Medical University, Changchun Street 45#, Beijing 100053, China[2]Central Hospital of Cangzhou, Xinhua Middle Street 201#, Cangzhou, Hebei Province 061001, China[3]Department of Life Sciences, The National Natural Science Foundation of China, Shuangqing Road 83#, Beijing 100085, China
推荐引用方式(GB/T 7714):
Linpei Jia,Rufu Jia,Yinping Li,et al.LCK as a Potential Therapeutic Target for Acute Rejection after Kidney Transplantation: A Bioinformatics Clue[J].JOURNAL OF IMMUNOLOGY RESEARCH.2018,2018:doi:10.1155/2018/6451298.
APA:
Linpei Jia,Rufu Jia,Yinping Li,Xiaoxia Li,Qiang Jia&Hongliang Zhang.(2018).LCK as a Potential Therapeutic Target for Acute Rejection after Kidney Transplantation: A Bioinformatics Clue.JOURNAL OF IMMUNOLOGY RESEARCH,2018,
MLA:
Linpei Jia,et al."LCK as a Potential Therapeutic Target for Acute Rejection after Kidney Transplantation: A Bioinformatics Clue".JOURNAL OF IMMUNOLOGY RESEARCH 2018.(2018)